InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials

Stock Information for NanoViricides Inc.

Loading

Please wait while we load your information from QuoteMedia.